DOI: 10.1055/s-00000019

Fortschritte der Neurologie · Psychiatrie

References

Mathis M V, Muoio BM, Andreason P. et al.
The US Food and Drug Administrationʼs perspective on the new antipsychotic pimavanserin.

J Clin Psychiat 2017;
78: 668-673

Download Bibliographical Data

Search in:
Access: